The Discounted Cash Flow (DCF) valuation of Inhibrx Inc (INBX) is 1,075.55 USD. With the latest stock price at 37.25 USD, the upside of Inhibrx Inc based on DCF is 2787.4%.
Based on the latest price of 37.25 USD and our DCF valuation, Inhibrx Inc (INBX) is a buy. buying INBX stocks now will result in a potential gain of 2787.4%.
| Range | Selected | |
| WACC / Discount Rate | 7.8% - 11.4% | 9.6% |
| Long-term Growth Rate | 0.0% - 1.0% | 0.5% |
| Fair Price | 876.10 - 1,409.22 | 1,075.55 |
| Upside | 2251.9% - 3683.1% | 2787.4% |